Loading
Latest filing published 15 May 2024 for Diamyd Medical Aktiebolag, €21k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Mark Atkinson is a declared insider of Diamyd Medical Aktiebolag, with filings sourced from Finansinspektionen. The record holds 2 filings, for trades running from 17 December 2020 to 14 May 2024.
The open-market record is one-sided, with 2 purchases worth €51k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2024 to date brings 1 purchase and no sales.
The latest filing, published on 15 May 2024, reports an open-market purchase of €21k in Diamyd Medical Aktiebolag. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations